Keyphrases
Acceptor Unit
14%
Activity Level
28%
Activity Retention
100%
Ala-Tyr
14%
Biodistribution
28%
Cholecystokinin-2 Receptor
42%
D-Glu
85%
Decreased Activity
14%
Fluoride
100%
Glutamic Acid
14%
Hybrid Radio
100%
IC50
42%
IC50 Value
14%
In Vivo Properties
14%
Increased Activity
14%
Kidney
100%
L-glutamine
14%
Ligand-receptor Binding
14%
Linker
28%
Linker Sequence
100%
Lipophilicity
28%
LogD7.4
28%
Lutetium-177 (177Lu)
28%
Minigastrin Analogue
100%
Negative Charge
28%
Negatively Charged
28%
P-silicon
42%
Polyethylene Glycol
100%
Positively Charged
14%
Receptor Affinity
28%
Silicon-based
100%
Therapeutic Use
14%
Tumor
42%
Tumor Retention
14%
Tumor Uptake
28%
Tumor-to-background Ratio
14%
Medicine and Dentistry
Biodistribution
25%
Cholecystokinin B Receptor
37%
Drug Therapy
12%
Glutamic Acid
25%
IC50
50%
In Vitro
25%
Lutetium 177
25%
Macrogol
87%
Neoplasm
87%
Receptor Affinity
25%
Tetraxetan
100%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
25%
Cholecystokinin B Receptor
37%
Glutamic Acid
25%
IC50
50%
Lipophilicity
25%
Lutetium 177
25%
Macrogol
87%
Neoplasm
87%
Tetraxetan
100%
Therapeutic Use
12%
Chemistry
Ala-Tyr
12%
Asp-Phe
12%
Cholecystokinin
37%
D-Glutamic Acid
12%
DOTA
100%
Glutamic Acid
12%
Gly-Trp
12%
IC50
50%
Lipophilicity
25%
Poly(ethylene Glycol)
87%
Silicon
87%
Neuroscience
Cholecystokinin B Receptor
42%
Glutamic Acid
28%
In Vitro
28%
In Vivo
42%
Macrogol
100%
Receptor Affinity
28%